Regulatory Turbulence Hits Dabur: USFDA Warning, Court Relief, & AGM Updates
USFDA warns Dabur on GMP gaps, Delhi High Court restores “100 % Pure” claim, amid AGM‑board changes and volatile stock; investors watch compliance turnaround.
3 minutes to read